Markers for the Diagnosis of Biochemical Recurrence in Prostate Cancer
Summary
USPTO published patent application US20260092922A1 for biomarkers and diagnostic methods related to prostate cancer biochemical recurrence (BCR). The application (No. 19207308, filed May 13, 2025) includes 9 inventors and covers methods for detecting BCR biomarkers, compositions, and diagnostic kits. This is a routine patent publication with no new regulatory requirements.
What changed
USPTO published patent application US20260092922A1 on April 2, 2026, disclosing methods and compositions for diagnosing biochemical recurrence (BCR) in prostate cancer through biomarker detection. Application No. 19207308 was filed May 13, 2025, listing 9 inventors including Michael Kiebish and colleagues. The claimed invention includes diagnostic methods and kits/panels for detecting BCR biomarkers.
This publication does not create new regulatory obligations. Entities conducting prostate cancer diagnostics, biomarker research, or developing related diagnostic kits should review the claims to assess potential patent landscape implications, freedom-to-operate concerns, or licensing opportunities. No compliance deadline or enforcement action applies to this document.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MARKERS FOR THE DIAGNOSIS OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER
Application US20260092922A1 Kind: A1 Apr 02, 2026
Inventors
Michael Andrew Kiebish, Niven Rajin Narain, Rangaprasad Sarangarajan, Viatcheslav R. Akmaev, Leonardo Rodrigues, Lixia Zhang, Eric Milliman, Shiv Srivastava, Albert Dobi, Jennifer Cullen
Abstract
Methods for diagnosing the presence of BCR in prostate cancer in a subject are provided, such methods including the detection of levels of a variety of biomarkers diagnostic of BCR. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.
CPC Classifications
G01N 33/57555 A61P 35/00 G01N 2333/775 G01N 2405/04 G01N 2800/54 G01N 2800/60
Filing Date
2025-05-13
Application No.
19207308
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.